Panacea Life Sciences Holdings Inc · OTC:PLSH

Panacea Life Sciences — Exactus — Investor Presentation (February 2020)

23 slides from Panacea Life Sciences's investor presentation, Feb 18, 2020

  1. Slide 1: Compliance and Scalability for Mass Market Adoption

    “COMPLIANCE AND SCALABILITY - FOR MASS MARKET ADOPTION-... <=

  2. Slide 2: Cautionary Note Regarding Forward-Looking Statements

    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements. You can identify forward-looking statements in this presentation by use of the words “potential,” “expect,” “anticipate,” “target” and similar terminology. Such forward-looking statements incl

  3. Slide 3: Building a Trusted Hemp Derivatives Platform

    BUILDING A TRUSTED HEMP DERIVATIVES PLATFORM icy \ . Independent laboratory tested products Traceability from cultivation to end consumer a —— Highly scalable hemp farming knowledge base i, 77; & <> MARKET FACTS ZS * OTCQB SYMBOL: EXDI * Market cap ¥$13.5 million* * Fully reporting

  4. Slide 4: Federal Legalization of Hemp

    FEDERAL LEGALIZATION OF HEMP 2018 Farm Bill legalized hemp*, shifts hemp production regulation from the Drug Enforcement Agency (DEA) to the United States Department of Agriculture (USDA) at the Federal Level * Significant growth catalyst for industry * Industrial hemp and its byproducts are not inc

  5. Slide 5: US Hemp-Derived CBD Market Forecast

    US HEMP-DERIVED CBD MARKET FORECAST Hemp-derived CBD has been gaining huge momentum...We believe the hemp CBD market is going to skyrocket and is here to stay. 2: The Brightfield Grou

  6. Slide 6: The Endocannabinoid System (ECS)

    THE ENDOCANNABINOID SYSTEM (ECS) A physiological system of receptor networks supporting Anxiety wanes good health* oe ae ae Potential Health and Wellness Applications for so Hemp Derivatives Inflammatory /{ Epilepsy Seizures Cannabinoids stimulate the receptors located throughout the body and suppor

  7. Slide 7: Experience in Wellness, Health & Farming

    EXPERIENCE IN WELLNESS, HEALTH & FARMING EMILIANO ALO! PRESIDENT & CEO Co-founder of Ceed2Med Agro-industrial supply and market development expertise. Co- sponsored research programs for Stevia and Aloe Vera in 2012. &® Gen ~ LOMA NEGRA a 60 & DEREK DU CHESNE KENNETH E. PUZDER ANDREW L. JOHNSON CHIE

  8. Slide 8: Timeline & Milestones

    TIMELINE & MILESTONES A Q1 2019 © J Q2 2019 - Executed Ceed2Med - Initiated Master Supply & farming Development Agreement. operations. - Established farming - Acquired location. Green Goddess - Placed initial product Extracts order. consumer products brand. f Q3 2019 - E-commerce platform launched.

  9. Slide 9: Two Industrial Hemp Farms in Oregon

    gam AN = PS) Two Industrial Hemp Farms in Oregon * Controlling ownership stake (50.1%) * Superior seed genetics * Successful harvest history * Purchased the rights for 100% of the 2020 harvest Organic and Proprietary Farming Techniques + All-natural processes and products * Top flower harvest for sa

  10. Slide 10: Traceability from Cultivation to Consumer

    10 TRACEABILITY FROM CULTIVATION TO CONSUMER GMP Formulations and Manufacturing a ® Retailer Wholesaler @ t Test and Q © Analysis GMP od) Extraction ° (i Certified Genetics Direct to Consumer Consumer All-natural TRANSPARENCY Cultivation Build trust with full Transportation transparency through enti

  11. Slide 11: Full Transparency

    FULL TRANSPARENCY Lab Results ¢ Product Description * Product Technical Specifications * Certificate of Analysis of Product * Active Ingredient Technical Specifications * Active Ingredient Third-Party CoA * Strain and Batch Flower Specifications ¢ Strain and Batch Third-Party CoA * Materials Safety

  12. Slide 12: Growth Strategy

    GROWTH STRATEGY Developing a Hemp-derived Ecosystem Supported By Best-in-Class Industry Practices Operations Platform Growth Drivers >) Farm = T ice I New Products Marketing and Brand Development & | Processing E Manufacturing Se Expand Distribution exactus We

  13. Slide 13: The Plan: Develop a Hemp-Derived Specialty Ingredients Ecosystem

    THE PLAN: DEVELOP A HEMP-DERIVED SPECIALTY INGREDIENTS ECOSYSTEM * Launch Exactus family of branded products = - * Build targeted consumer-facing distribution sos various channels LAA yor , y, * Build brand awareness if r — ™~ vA E-commerce (D2C) Wholesale (B2B) Big-box retail distribution “ Special

  14. Slide 14: Building Out Product Lines

    BUILDING OUT PRODUCT LINES exactus Launch Hemp Derived Products yr SS * Tinctures, topicals, edibles and new delivery systems in development @ * Green Goddess Extracts product portfolio targets cada millennial segment through e-commerce and brick and mortar distribution channels * LeVor Collection t

  15. Slide 15: Exactus Branded Products

    EXACTUS BRANDED PRODUCTS Build a House of Brands Supported by Exactus’ Quality Strategy: Develop and acquire brands to service under the Exactus ecosystem supported by our standards of quality and compliance . Develop products from our compliant full spectrum of whole plant extract distillates (broa

  16. Slide 16: Distribution Channel Build-Out Plan

    16 DISTRIBUTION CHANNEL BUILD-OUT PLAN * Streamlining E-commerce platform and developing an Amazon portal by our highly experienced team with track record of successful algorithm-based sales in similar sectors * Wholesale distribution through existing relationships + Will target pharmacy sales of he

  17. Slide 17: Medical Delivery Systems

    MEDICAL DELIVERY SYSTEMS On Nov. 20**, 2019 Exactus signed a Supply & Distribution agreement with Canntab Therapeutics Inc. to produce immediate and extended release tablets. 13 Patents Pending in the United States and Canada covering our proprietary processes and hard pill formulations for: + Exten

  18. Slide 18: Growth Opportunities

    GROWTH OPPORTUNITIES Summary Balance Sheet Potential Near-Term Sources of Cash * Sales of top flower Cash $5,686 Se * Sales of hemp-derived specialty ingredients Current Assets 3,255,169 * If needed, closing of second and third Total Assets 11,499,203 tranches of $2mm note Current Liabilities 2,052,

  19. Slide 19: Investment Thesis Summary

    INVESTMENT THESIS SUMMARY Controlling ownership in industrial hemp farms assures control and access to high quality hemp supply for commercialization Full control from seed to market provides product quality control and supports brand strength Generating revenue in Q1 of 2020 from distribution of a

  20. Slide 20: Safety and Scalability

    SAFETY AND SCALABILITY For further information contact: Emiliano Aloi, President & CEO Email emi@exactusinc.com Andrew Johnson, Chief Strategy Officer Email ajohnson@exactusinc.com exactus Nw exactus IN

  21. Slide 21: Appendix Slides

    Appendix Slides

  22. Slide 22: Board of Directors

    BOARD OF DIRECTORS BOBBY YAMPOLSKY Director * Founder ECJ Luxe, a family-owned luxury shopping destination that specializes in an array of ultra-exclusive items including everything from high end time pieces, jewelry and diamonds, to exotic cars and yachts. * Co-Founder and CEO of Ceed2Med, LLC, a h

  23. Slide 23: Board of Directors - Continued

    BOARD OF DIRECTORS - Continued JOHN PRICE Independent Director + John Price currently serves as Chief Financial Officer, Treasurer and Secretary of SCWorx Corp., a publicly-traded provider of data normalization, application interoperability and big data analytics within the healthcare provider marke

Exactus — Investor Presentation (February 2020) on 6ix